Brand Name(s): Rituxan; Mabthera
CAS nº: 174722-31-7
(rih tux ih mab)

About Rituximab

This site is dedicated exclusively to rituximab.

It provides you with the most extensive product information and up-to-date resources regarding this medication, including related news articles, medical studies, an image library and all the necessary information on dosage and side effects.

Whether you are an average consumer or a pharma industry professional, you can now find out everything you need to know about rituximab on this reference site, as well as take part in our open discussion forum by sharing your own knowledge and experience with people who are using this medication.

This unique site will also provide you with inside industry news on which companies or organizations are playing an important part in its research, development, production and promotion. It is your one-stop site for a total rituximab experience! 

Why is this medication prescribed?

Rituximab is a cancer (antineoplastic) medication. It works by interfering with the growth of cancer cells by slowing their growth and spread in the body.

Rituximab is also used in the treatment of non-Hodgkin's lymphoma.

Additionally, this medication can be used alone or in combination with other chemotherapeutic drugs. Specifically, very good results have been seen when used in combination with the CHOP chemotherapy regimen (cyclophosphamide, doxorubicin, vincristine, and prednisone).

Rituximab is sold as Rituxan® in the United States.

See more Product Info

Latest News

Cancer Drug Slows Multiple Sclerosis Progression

Two shots of the cancer drug Rituxan given two weeks apart slowed the progression of multiple...

[more]

Role of Mitoxantrone in Combination Therapy for Chronic Lymphocytic Leukemia (CLL) Evaluated

Researchers from Spain have reported preliminary results of initial treatment of patients with...

[more]

MabThera(REG) Helps Patients With Lymphoma Stay Symptom Free And Live Longer

A study published recently in Blood, the journal of the American Society of Hematology, has...

[more]

FDA Issues Safety Warning On Biogen Drug; Stock Is Falling

Monday, the U.S. Food and Drug Administration or FDA issued a warning to healthcare professionals...

[more]

This site is intended solely for U.S. audiences; products described here may be subject to different medical and/or regulatory requirements in other countries. This site is for educational purposes only; information contained within should not be used to diagnose or treat a health problem or disease. Please consult a licensed health care provider regarding your medical condition.The products mentioned are trademarks of their respective owners.